title: Severe efavirenz-induced vacuolar axonopathy complicated by fatal aspiration pneumonia.
authors.forename: Chris
authors.initials: C
authors.lastname: Kenyon
authors.forename: Sipho
authors.initials: S
authors.lastname: Mfolozi
authors.forename: Roland
authors.initials: R
authors.lastname: Croxford
authors.forename: Robert
authors.initials: R
authors.lastname: Colebunders
authors.forename: Karen
authors.initials: K
authors.lastname: Cohen
mesh_terms: D000328:Adult; D000480:Alkynes; D019380:Anti-HIV Agents / Q000009:adverse effects*; D001369:Axons / Q000187:drug effects; D048588:Benzoxazines / Q000009:adverse effects*; D003521:Cyclopropanes; D006970:Disorders of Excessive Somnolence / Q000139:chemically induced*; D004305:Dose-Response Relationship, Drug; D017809:Fatal Outcome; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D011015:Pneumonia, Aspiration / Q000150:complications*; D013019:South Africa; D015030:Zimbabwe
chemical_list: D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; C098320:efavirenz